30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Providers & Services

Oncology Institute Inc (TOI)

Track

Over the last 90 days, Oncology Institute Inc. has seen a net buy value of $636,984.84 from insiders, with a total of 13 transactions. Notably, "Chernett Jorey" has been a consistent buyer, acquiring shares across multiple dates. Conversely, "YALE PODNOS" and "Kaushal Mohit" have engaged in planned or proposed sales.
Stock chart
Ticker: TOI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Chernett Jorey
1 purchase — total 100,000 USD
Buy 23 Jun 2026
Value US$3,188,658.99 | Price 351.35 | Shares 71,554
Planned sale 8 Jun 2026
Value US$391,204.76 | Price 398.36 | Shares 6,319
Proposed sale 8 Jun 2026
Value US$100,000.00 | Price 4.87 | Shares 1,000
Buy 4 Jun 2026
Value US$100,000.00 | Price 4.75 | Shares 1,000
Buy 20 May 2026
Value US$136,345.00 | Price 4.07 | Shares 33,500
Buy 19 May 2026
Value US$20,250.00 | Price 4.05 | Shares 5,000
Buy 19 May 2026
Value US$122,700.00 | Price 4.09 | Shares 30,000
Planned sale 16 Apr 2026
Value US$134,534.72 | Price 3.50 | Shares 38,433
Planned sale 14 Apr 2026
Value US$200,598.39 | Price 3.50 | Shares 57,286
Proposed sale 14 Apr 2026
Value US$315,872.70 | Price 3.30 | Shares 95,719
Buy 9 Apr 2026
Value US$62,000.00 | Price 3.10 | Shares 20,000
Buy 27 Mar 2026
Value US$81,189.84 | Price 2.96 | Shares 27,429
Buy 26 Mar 2026
Value US$157,500.00 | Price 3.15 | Shares 50,000
Buy 24 Mar 2026
Value US$388,750.00 | Price 3.11 | Shares 125,000
Buy 20 Mar 2026
Value US$83,750.00 | Price 3.35 | Shares 25,000
Buy 17 Mar 2026
Value US$256,500.00 | Price 3.42 | Shares 75,000
Buy 16 Mar 2026
Value US$200,640.65 | Price 3.29 | Shares 60,985
Buy 13 Mar 2026
Value US$767,960.00 | Price 2.92 | Shares 263,000
Sale 2 Jan 2026
Value US$879.32 | Price 3.56 | Shares 247
Sale 15 Dec 2025
Value US$50,290.74 | Price 3.77 | Shares 13,333
Proposed sale 15 Dec 2025
Value US$50,290.74 | Price 3.77 | Shares 13,333
Sale 18 Nov 2025
Value US$186,520.00 | Price 4.00 | Shares 46,630
Sale 18 Nov 2025
Value US$4,840.00 | Price 4.00 | Shares 1,210
Sale 18 Nov 2025
Value US$8,640.00 | Price 4.00 | Shares 2,160
Proposed sale 18 Nov 2025
Value US$200,000.00 | Price 4.00 | Shares 50,000
Sale 4 Sep 2025
Value US$2,106,860.88 | Price 3.09 | Shares 681,832
Sale 4 Sep 2025
Value US$18,596,139.12 | Price 3.09 | Shares 6,018,168
Sale 19 Aug 2025
Value US$82,097.26 | Price 4.06 | Shares 20,221
Sale 5 Jun 2025
Value US$232,788.20 | Price 3.05 | Shares 76,324
Sale 5 Jun 2025
Value US$2,054,711.80 | Price 3.05 | Shares 673,676
Proposed sale 5 Jun 2025
Value US$3,592,937.60 | Price 3.20 | Shares 1,122,793
Proposed sale 5 Jun 2025
Value US$407,062.40 | Price 3.20 | Shares 127,207
Sale 3 Jun 2025
Value US$311,519.40 | Price 2.87 | Shares 108,532
Sale 3 Jun 2025
Value US$5,360,586.63 | Price 2.87 | Shares 1,867,605
Proposed sale 3 Jun 2025
Value US$113,652.00 | Price 2.87 | Shares 39,600
Proposed sale 3 Jun 2025
Value US$5,557,861.19 | Price 2.87 | Shares 1,936,537
Sale 20 May 2025
Value US$552,161.96 | Price 2.71 | Shares 203,532
Sale 20 May 2025
Value US$4,873,638.04 | Price 2.71 | Shares 1,796,468
Proposed sale 20 May 2025
Value US$5,497,192.08 | Price 3.06 | Shares 1,796,468
Proposed sale 20 May 2025
Value US$622,807.92 | Price 3.06 | Shares 203,532
Buy 26 Mar 2025
Value US$23,584.09 | Price 1.04 | Shares 22,640
Buy 26 Mar 2025
Value US$94,338.44 | Price 1.04 | Shares 90,562
Buy 26 Mar 2025
Value US$9,433.64 | Price 1.04 | Shares 9,056
Buy 26 Mar 2025
Value US$9,433.64 | Price 1.04 | Shares 9,056
Buy 26 Mar 2025
Value US$9,433.64 | Price 1.04 | Shares 9,056
Buy 26 Mar 2025
Value US$37,734.54 | Price 1.04 | Shares 36,224
Buy 26 Mar 2025
Value US$9,433.64 | Price 1.04 | Shares 9,056
Buy 26 Mar 2025
Value US$1,415,095.28 | Price 1.04 | Shares 1,358,448
Buy 2 Dec 2024
Value US$7,500.00 | Price 0.15 | Shares 50,000
Buy 26 Nov 2024
Value US$42,500.00 | Price 0.17 | Shares 250,000
Sale 29 Jan 2024
Value US$18,310.44 | Price 2.12 | Shares 8,637
Sale 26 Jan 2024
Value US$14,935.06 | Price 2.14 | Shares 6,979
Sale 25 Jan 2024
Value US$24,595.74 | Price 2.07 | Shares 11,882
Sale 24 Jan 2024
Value US$57,304.50 | Price 2.30 | Shares 24,915
Sale 23 Jan 2024
Value US$11,263.18 | Price 2.11 | Shares 5,338
Sale 22 Jan 2024
Value US$21,757.56 | Price 2.12 | Shares 10,263
Sale 19 Jan 2024
Value US$25,530.18 | Price 2.13 | Shares 11,986
Proposed sale 19 Jan 2024
Value US$171,200.00 | Price 2.14 | Shares 80,000
Buy 14 Dec 2023
Value US$706.25 | Price 1.25 | Shares 565
Buy 14 Dec 2023
Value US$126,282.45 | Price 1.27 | Shares 99,435
Sale 17 Nov 2023
Value US$56,000.00 | Price 2.24 | Shares 25,000
Proposed sale 17 Nov 2023
Value US$56,000.00 | Price 2.24 | Shares 25,000
Sale 13 Nov 2023
Value US$118,581.00 | Price 2.52 | Shares 47,000
Proposed sale 13 Nov 2023
Value US$118,588.52 | Price 2.52 | Shares 47,000
Buy 17 Mar 2023
Value US$5,500.00 | Price 0.55 | Shares 10,000
Buy 17 Mar 2023
Value US$5,500.00 | Price 0.55 | Shares 10,000
Buy 17 Mar 2023
Value US$1,176.01 | Price 0.55 | Shares 2,146
Buy 17 Mar 2023
Value US$4,209.70 | Price 0.55 | Shares 7,654
Buy 17 Mar 2023
Value US$5,471.40 | Price 0.55 | Shares 9,948
Buy 17 Mar 2023
Value US$109.60 | Price 0.55 | Shares 200
Buy 17 Mar 2023
Value US$28.55 | Price 0.55 | Shares 52
Buy 17 Mar 2023
Value US$5,500.00 | Price 0.55 | Shares 10,000
Buy 16 Dec 2022
Value US$69,999.80 | Price 0.95 | Shares 73,684
Planned sale 14 Nov 2022
Value US$34,083.21 | Price 2.13 | Shares 15,994
Sale 11 Nov 2022
Value US$851,197.93 | Price 2.33 | Shares 365,321
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-23 B Purchase
Chernett Jorey
Large shareholder
71,554 +29.8%
351.35
US$3,188,659 		71,554 +29.8% 351.35 US$3,188,659
2026-06-09 2026-06-08 PlS Planned sale
Podnos Yale

Chief Medical Officer

Officer
6,319 -17.5%
398.36
US$391,205 		6,319 -17.5% 398.36 US$391,205
2026-06-08 2026-06-08 PrS Proposed sale
YALE PODNOS

Officer

Officer
84,676
211.60
US$3,717,616 		84,676 211.60 US$3,717,616
2026-06-05 2026-06-04 B Purchase
Chernett Jorey
Large shareholder
1,000 +0.1%
4.75
US$100,000 		1,000 +0.1% 4.75 US$100,000
2026-05-21 2026-05-20 B Purchase
Chernett Jorey
Large shareholder
33,500 +0.3%
4.07
US$136,345 		33,500 +0.3% 4.07 US$136,345
2026-05-21 2026-05-19 B Purchase
Chernett Jorey
Large shareholder
5,000 +0.0%
4.05
US$20,250 		5,000 +0.0% 4.05 US$20,250
2026-05-20 2026-05-19 B Purchase
Chernett Jorey
Large shareholder
30,000 +0.3%
4.09
US$122,700 		30,000 +0.3% 4.09 US$122,700
2026-04-16 2026-04-16 PlS Planned sale
Kaushal Mohit
Non-Executive Director
38,433 -18.2%
3.50
US$134,535 		38,433 -18.2% 3.50 US$134,535
2026-04-16 2026-04-14 PlS Planned sale
Kaushal Mohit
Non-Executive Director
57,286 -21.4%
3.50
US$200,598 		57,286 -21.4% 3.50 US$200,598
2026-04-14 2026-04-14 PrS Proposed sale
MOHIT KAUSHAL

Director

Non-Executive Director
95,719
3.30
US$315,873 		95,719 3.30 US$315,873
2026-04-13 2026-04-09 B Purchase
Chernett Jorey
Large shareholder
20,000 +0.2%
3.10
US$62,000 		20,000 +0.2% 3.10 US$62,000
2026-03-30 2026-03-27 B Purchase
Chernett Jorey
Large shareholder
27,429 +0.3%
2.96
US$81,190 		27,429 +0.3% 2.96 US$81,190
2026-03-27 2026-03-26 B Purchase
Chernett Jorey
Large shareholder
50,000 +0.5%
3.15
US$157,500 		50,000 +0.5% 3.15 US$157,500
2026-03-25 2026-03-24 B Purchase
Chernett Jorey
Large shareholder
125,000 +1.2%
3.11
US$388,750 		125,000 +1.2% 3.11 US$388,750
2026-03-23 2026-03-20 B Purchase
Chernett Jorey
Large shareholder
25,000 +0.2%
3.35
US$83,750 		25,000 +0.2% 3.35 US$83,750
2026-03-17 2026-03-17 B Purchase
Chernett Jorey
Large shareholder
75,000 +0.7%
3.42
US$256,500 		75,000 +0.7% 3.42 US$256,500
2026-03-17 2026-03-16 B Purchase
Chernett Jorey
Large shareholder
60,985 +0.6%
3.29
US$200,641 		60,985 +0.6% 3.29 US$200,641
2026-03-17 2026-03-13 B Purchase
Chernett Jorey
Large shareholder
263,000 +2.7%
2.92
US$767,960 		263,000 +2.7% 2.92 US$767,960
2026-01-05 2026-01-02 S Sale
2.4
Carter Robert Ross

Chief Financial Officer

Officer
247 -0.1%
3.56
US$879 		247 -0.1% 3.56 US$879
2025-12-16 2025-12-15 S Sale
3.1
Hively Brad
Non-Executive Director
13,333 -1.9%
3.77
US$50,291 		13,333 -1.9% 3.77 US$50,291
2025-12-15 2025-12-15 PrS Proposed sale
3.1
BRADFORD DANIEL HIVELY

Director

Non-Executive Director
13,333
3.77
US$50,291 		13,333 3.77 US$50,291
2025-11-20 2025-11-18 S Sale
3.1
Pacala Mark L
Non-Executive Director
46,630 -21.0%
4.00
US$186,520 		46,630 -21.0% 4.00 US$186,520
2025-11-20 2025-11-18 S Sale
3.1
Pacala Mark L
Non-Executive Director
1,210 -0.5%
4.00
US$4,840 		1,210 -0.5% 4.00 US$4,840
2025-11-20 2025-11-18 S Sale
3.1
Pacala Mark L
Non-Executive Director
2,160 -1.0%
4.00
US$8,640 		2,160 -1.0% 4.00 US$8,640
2025-11-18 2025-11-18 PrS Proposed sale
3.1
MARK PACALA

Director

Non-Executive Director
50,000
4.00
US$200,000 		50,000 4.00 US$200,000
2025-09-05 2025-09-04 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
681,832 -53.6%
3.09
US$2,106,861 		681,832 -53.6% 3.09 US$2,106,861
2025-09-05 2025-09-04 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
6,018,168 -43.1%
3.09
US$18,596,139 		6,018,168 -43.1% 3.09 US$18,596,139
2025-08-21 2025-08-19 S Sale
3.1
Hively Brad
Non-Executive Director
20,221 -3.1%
4.06
US$82,097 		20,221 -3.1% 4.06 US$82,097
2025-06-09 2025-06-05 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
76,324 -5.7%
3.05
US$232,788 		76,324 -5.7% 3.05 US$232,788
2025-06-09 2025-06-05 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
673,676 -4.6%
3.05
US$2,054,712 		673,676 -4.6% 3.05 US$2,054,712
2025-06-05 2025-06-05 PrS Proposed sale
TOI M, LLC

10% Stockholder

Large shareholder
127,207
3.20
US$407,062 		127,207 3.20 US$407,062
2025-06-05 2025-06-05 PrS Proposed sale
1.8
M33 Growth I L.P.

10% Stockholder

Large shareholder
1,122,793
3.20
US$3,592,938 		1,122,793 3.20 US$3,592,938
2025-06-05 2025-06-03 S Sale
3.1
Hively Brad
Non-Executive Director
108,532 -15.2%
2.87
US$311,519 		108,532 -15.2% 2.87 US$311,519
2025-06-05 2025-06-03 S Sale
3.1
Hively Brad
Non-Executive Director
1,867,605 -72.4%
2.87
US$5,360,587 		1,867,605 -72.4% 2.87 US$5,360,587
2025-06-03 2025-06-03 PrS Proposed sale
3.1
BRADFORD DANIEL HIVELY

Director

Non-Executive Director
39,600
2.87
US$113,652 		39,600 2.87 US$113,652
2025-06-03 2025-06-03 PrS Proposed sale
3.1
BRADFORD DANIEL HIVELY

Director

Non-Executive Director
1,936,537
2.87
US$5,557,861 		1,936,537 2.87 US$5,557,861
2025-05-22 2025-05-20 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
203,532 -13.1%
2.71
US$552,162 		203,532 -13.1% 2.71 US$552,162
2025-05-22 2025-05-20 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
1,796,468 -10.9%
2.71
US$4,873,638 		1,796,468 -10.9% 2.71 US$4,873,638
2025-05-20 2025-05-20 PrS Proposed sale
TOI M, LLC

10% Stockholder

Large shareholder
203,532
3.06
US$622,808 		203,532 3.06 US$622,808
2025-05-20 2025-05-20 PrS Proposed sale
1.8
M33 Growth I L.P.

10% Stockholder

Large shareholder
1,796,468
3.06
US$5,497,192 		1,796,468 3.06 US$5,497,192
2025-03-28 2025-03-26 B Purchase
Virnich Daniel

Chief Executive Officer

Officer
22,640 +3.2%
1.04
US$23,584 		22,640 +3.2% 1.04 US$23,584
2025-03-28 2025-03-26 B Purchase
3.1
Pacala Mark L
Non-Executive Director
90,562 +67.4%
1.04
US$94,338 		90,562 +67.4% 1.04 US$94,338
2025-03-28 2025-03-26 B Purchase
Podnos Yale

Chief Medical Officer

Officer
9,056 +12.9%
1.04
US$9,434 		9,056 +12.9% 1.04 US$9,434
2025-03-28 2025-03-26 B Purchase
3.1
Hively Brad
Non-Executive Director
9,056 +1.4%
1.04
US$9,434 		9,056 +1.4% 1.04 US$9,434
2025-03-28 2025-03-26 B Purchase
Castle Jeremy

Chief Operating Officer

Officer
9,056 +11.1%
1.04
US$9,434 		9,056 +11.1% 1.04 US$9,434
2025-03-28 2025-03-26 B Purchase
Johnson Karen Marie
Non-Executive Director
36,224 +21.7%
1.04
US$37,735 		36,224 +21.7% 1.04 US$37,735
2025-03-28 2025-03-26 B Purchase
2.4
Carter Robert Ross

Chief Financial Officer

Officer
9,056 +29.8%
1.04
US$9,434 		9,056 +29.8% 1.04 US$9,434
2025-03-28 2025-03-26 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
1,358,448 +325.6%
1.04
US$1,415,095 		1,358,448 +325.6% 1.04 US$1,415,095
2024-12-02 2024-12-02 B Purchase
3.1
Hively Brad
Non-Executive Director
50,000 +8.1%
0.15
US$7,500 		50,000 +8.1% 0.15 US$7,500
2024-12-02 2024-11-26 B Purchase
3.1
Hively Brad
Non-Executive Director
250,000 +68.2%
0.17
US$42,500 		250,000 +68.2% 0.17 US$42,500
2024-01-30 2024-01-29 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
8,637 -100.0%
2.12
US$18,310 		8,637 -100.0% 2.12 US$18,310
2024-01-26 2024-01-26 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
6,979 -44.7%
2.14
US$14,935 		6,979 -44.7% 2.14 US$14,935
2024-01-26 2024-01-25 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
11,882 -43.2%
2.07
US$24,596 		11,882 -43.2% 2.07 US$24,596
2024-01-26 2024-01-24 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
24,915 -47.5%
2.30
US$57,304 		24,915 -47.5% 2.30 US$57,304
2024-01-23 2024-01-23 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
5,338 -9.2%
2.11
US$11,263 		5,338 -9.2% 2.11 US$11,263
2024-01-23 2024-01-22 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
10,263 -15.1%
2.12
US$21,758 		10,263 -15.1% 2.12 US$21,758
2024-01-23 2024-01-19 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
11,986 -15.0%
2.13
US$25,530 		11,986 -15.0% 2.13 US$25,530
2024-01-19 2024-01-19 PrS Proposed sale
Havencrest Healthcare Partners GP, LLC

10% Stockholder

Large shareholder
80,000
2.14
US$171,200 		80,000 2.14 US$171,200
2023-12-18 2023-12-14 B Purchase
3.1
Shah Mihir

Chief Financial Officer

Officer
565 +0.2%
1.25
US$706 		565 +0.2% 1.25 US$706
2023-12-18 2023-12-14 B Purchase
3.1
Shah Mihir

Chief Financial Officer

Officer
99,435 +43.6%
1.27
US$126,282 		99,435 +43.6% 1.27 US$126,282
2023-11-21 2023-11-17 S Sale
3.1
Hively Brad
Non-Executive Director
25,000 -3.5%
2.24
US$56,000 		25,000 -3.5% 2.24 US$56,000
2023-11-17 2023-11-17 PrS Proposed sale
3.1
Hively Brad

Director

Non-Executive Director
25,000
2.24
US$56,000 		25,000 2.24 US$56,000
2023-11-15 2023-11-13 S Sale
3.1
Hively Brad
Non-Executive Director
47,000 -6.1%
2.52
US$118,581 		47,000 -6.1% 2.52 US$118,581
2023-11-13 2023-11-13 PrS Proposed sale
3.1
Hively Brad

Director

Non-Executive Director
47,000
2.52
US$118,589 		47,000 2.52 US$118,589
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
10,000 +4.0%
0.55
US$5,500 		10,000 +4.0% 0.55 US$5,500
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
10,000 +4.2%
0.55
US$5,500 		10,000 +4.2% 0.55 US$5,500
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
2,146 +0.9%
0.55
US$1,176 		2,146 +0.9% 0.55 US$1,176
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
7,654 +3.4%
0.55
US$4,210 		7,654 +3.4% 0.55 US$4,210
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
9,948 +4.6%
0.55
US$5,471 		9,948 +4.6% 0.55 US$5,471
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
200 +0.1%
0.55
US$110 		200 +0.1% 0.55 US$110
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
52 +0.0%
0.55
US$29 		52 +0.0% 0.55 US$29
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
10,000 +4.8%
0.55
US$5,500 		10,000 +4.8% 0.55 US$5,500
2022-12-20 2022-12-16 B Purchase
1.5
Miller Matthew P

Chief Operating Officer

Officer
73,684 +72.5%
0.95
US$70,000 		73,684 +72.5% 0.95 US$70,000
2022-11-15 2022-11-14 PlS Planned sale
Kaushal Mohit
Non-Executive Director
15,994 -38.5%
2.13
US$34,083 		15,994 -38.5% 2.13 US$34,083
2022-11-15 2022-11-11 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
365,321 -2.7%
2.33
US$851,198 		365,321 -2.7% 2.33 US$851,198
Explore more

More insider trading research around Oncology Institute Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America